You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser.
-
Axsome Therapeutics stock skyrockets on positive outcome from Alzheimer's disease trial
https://news.alphastreet.com/axsome-therapeutics-nasdaq-axsm-stock-almost-doubles-on-positive-outcome-from-alzheimers-disease-trial-in-premarket/
- anonymous
- Thread
-
alzhemier's disease
axsome therapeutics
biopharma
clinical trial
dementia
drug
eli lilly
fda
merck
pfizer
- Replies: 0
- Forum: Pharma/Biotech Companies - In the News
